Last reviewed · How we verify

NCT05560529

Dialectical Behavioral Therapy As A Therapeutic Tool In Patients With Binge Eating Disorder

Completed Phase 4 Last updated 29 January 2025
What this trial tests

Phase 4 trial testing DBT in Binge Eating Disorder in 60 participants. Completed in 15 September 2024.

Timeline
15 March 2023
Primary endpoint
15 June 2024
15 September 2024

Quick facts

Lead sponsorAlexandria University
PhasePhase 4
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment60
Start date15 March 2023
Primary completion15 June 2024
Estimated completion15 September 2024
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Alexandria University

Who can join

18 and older, any sex, with Binge Eating Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Binge eating disorder (BED) is one of the recently acknowledged eating disorders, with many theories underlying its pathology whether biological or psychological. From the biological perspective, changes in plasma ghrelin were hypothesized to have a major role in developing and maintaining the disorder, while from the psychopathological perspectives, abnormalities in emotion regulation were found in many patients. Since Dialectical Behavioral Therapy (DBT) is known to target emotion dysregulation, the main aim of this study is to assess the efficacy of DBT versus treatment as usual (TAU) in BED patients, and whether plasma ghrelin level will be affected after treatment in both arms.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of DBT

Trials testing the same drug.

Other recruiting trials for Binge Eating Disorder

Currently open trials in the same condition.

Other Alexandria University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05560529.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing